Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.

Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.

Item
http://www.wikidata.org/entity/Q34765145
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functionsLower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.Review article: new receptor targets for medical therapy in irritable bowel syndromeAre there functional β₃-adrenoceptors in the human heart?Scintigraphic biomarkers for colonic dysmotility.Methods for the assessment of small-bowel and colonic transit.Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.Recent advances in small bowel diseases: Part II.Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.Drug development for the irritable bowel syndrome: current challenges and future perspectivesChallenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Investigational agents for the irritable bowel syndrome.Existing and emerging therapies for irritable bowel syndrome.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder.Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental studies.Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges.
P2860

Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.

Item
http://www.wikidata.org/entity/Q34765145
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dose-response effect of a beta ...... somatostatin levels in health.
@ast
Dose-response effect of a beta ...... somatostatin levels in health.
@en
Dose-response effect of a beta ...... somatostatin levels in health.
@nl
type
label
Dose-response effect of a beta ...... somatostatin levels in health.
@ast
Dose-response effect of a beta ...... somatostatin levels in health.
@en
Dose-response effect of a beta ...... somatostatin levels in health.
@nl
prefLabel
Dose-response effect of a beta ...... somatostatin levels in health.
@ast
Dose-response effect of a beta ...... somatostatin levels in health.
@en
Dose-response effect of a beta ...... somatostatin levels in health.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Dose-response effect of a beta ...... somatostatin levels in health.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698